speb/financial-data huggingface dataset:
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Goodwill: 68440000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 411140000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 5012390000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 16273730000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Gross Profit: 8624100000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 133820000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Interest Expense: 398740000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 398740000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Interest Income: 34110000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 34110000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -346640000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 13300000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Inventory: 4940790000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 16457190000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -1892710000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 20420000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Investments In Other Ventures Under Equity Method: 10000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Investmentsin Subsidiariesat Cost: 100000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 12233690000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 106570000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 85560000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 4492060000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 4577620000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 2231910000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -1453480000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 110000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 282270000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 13884830000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Net Debt: 7971030000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 10570000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Net Income: 447690000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 447690000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 447690000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 447690000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 447690000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 597390000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 447690000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Net Interest Income: -406240000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 0.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -327520000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 778430000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -406240000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -1000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Net PPE: 11303310000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -1906010000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -1105950000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 7871100000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 74690000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 92870000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 716450000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 282270000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 138120000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 2139620000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Normalized Income: 448604280.12
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 2870470000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Operating Income: 1169640000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Operating Revenue: 22861650000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 69227250.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 5040000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 1300000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 33710000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 342700000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 20120000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 399940000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 67100000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 74690000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 9910000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 3259090000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Other Payable: 398460000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Other Properties: 10852560000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 497110000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 168070000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Other Special Charges: 640000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Payables: 5545540000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 27050000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 631800000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Pretax Income: 597390000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 29540000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: 0.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -1924010000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 1811420000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 14237550000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 1142270000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 122150000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 122150000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -12561210000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 90210000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 5949940000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 0.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 18000000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 172800000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 610500000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Share Issued: 69227250.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 10001780000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Short Term Debt Payments: -11107730000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Special Income Charges: -5100000.00
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 10840000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 8282240000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 7871100000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -305719.88
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Tax Provision: 149700000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.25
SUDARSCHEM.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -111760000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Total Assets: 23919850000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 12774300000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Total Debt: 8290520000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 8282240000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Total Expenses: 21692010000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 15637610000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 12271150000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 5704640000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 41610000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 20380000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -1220000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -1220000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Work In Process: 821360000.00
SUDARSCHEM.NS balance_sheet (annual, 2023-03-31) — Working Capital: 1715730000.00
SUDARSCHEM.NS income_statement (annual, 2023-03-31) — Write Off: 4460000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — +Operating Expense: 8543800000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — +Total Revenue: 25221940000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 5120460000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 5853190000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -6265930000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 133120000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -136640000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Amortization: 84470000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 40790000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 0.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 107730000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 69227250.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Basic EPS: 51.60
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 203920000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 2079830000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -784730000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 261350000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 138450000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 472370000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 472370000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -332910000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 0.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 472370000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 538180000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 57430000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -155770000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Change In Payable: 41260000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -965340000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -459830000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 268450000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Common Stock: 138450000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -332910000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 11490370000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 162620000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 14772400000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Current Assets: 11932800000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 34560000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Current Debt: 2476150000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 2510710000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 8624940000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 34950000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Depreciation: 1370880000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 1411670000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 1411670000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 1327200000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Derivative Product Liabilities: 0.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 69325280.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Diluted EPS: 51.60
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 3574470000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 59560000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — EBIT: 5055430000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — EBITDA: 6467100000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 0.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — End Cash Position: 472370000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Financial Assets: 12760000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 24300000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -4459310000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 2159210000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 1149820000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -75810000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -3151910000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 546160000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Goodwill: 68440000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 355460000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 5989830000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 17088960000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Gross Profit: 10449540000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 70350000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Interest Expense: 350130000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 350130000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Interest Income: 40560000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 40560000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -350070000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 40560000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Inventory: 4376000000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 15899670000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: 2793210000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 24300000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Investments In Other Ventures Under Equity Method: 10000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Investmentsin Subsidiariesat Cost: 100000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 0.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 110300000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 226790000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 1933150000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 2159940000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 0.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -2668290000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 110000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 317500000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 14736210000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 0.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Minority Interests: 0.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Net Debt: 3936930000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -2370000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Net Income: 3574470000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 3574470000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 3574470000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 3574470000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 3574470000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 4705300000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 3574470000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Net Interest Income: -348260000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 83350000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -3731090000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -2668290000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -369020000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Net PPE: 10823030000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: 2669300000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -1062800000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 11134910000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 30280000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 92170000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 911160000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 317500000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 143970000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 3259360000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Normalized Income: 1137649733.96
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 1934550000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Operating Income: 1905740000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Operating Revenue: 25221940000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 69227250.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 2360000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 3460000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 46320000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 287020000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 10010000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 317730000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 77840000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 30280000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 42170000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 3458270000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Other Payable: 407140000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Other Properties: 10397480000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 594450000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 161990000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Other Special Charges: -3151910000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Payables: 5613840000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 34950000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 477400000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Pretax Income: 4705300000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 12320000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -2650000000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -784730000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 1413390000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 14772400000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 1411670000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 317190000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 317190000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -2668290000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 86680000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Restructuring And Mergern Acquisition: 0.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 9197340000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 2733350000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 3454030000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 133830000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 679990000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Share Issued: 69227250.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 238270000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Short Term Debt Payments: -1301070000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Special Income Charges: 3120510000.00
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 12610000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 11490370000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 11134910000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 770919733.96
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Tax Provision: 1130830000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.24
SUDARSCHEM.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -835160000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Total Assets: 23550320000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 13423520000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Total Debt: 4670650000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 11490370000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Total Expenses: 23316200000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 12059950000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 11617520000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 3435010000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 38690000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 26680000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 3207740000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 3207740000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Work In Process: 793390000.00
SUDARSCHEM.NS balance_sheet (annual, 2024-03-31) — Working Capital: 3307860000.00
SUDARSCHEM.NS income_statement (annual, 2024-03-31) — Write Off: 31400000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 6007200000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 5640540000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 113860000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 281850000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 138450000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 311770000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 1876600000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 138450000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 12118480000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 317400000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 14643160000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 40340000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 4925910000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 4966250000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 12144810000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 42940000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Financial Assets: 1920000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 68440000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 316340000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 10625440000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Hedging Assets Current: 29060000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 6079570000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 17430700000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 113860000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 241510000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 386310000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 627820000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 331980000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 5000450000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 10625440000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 11802140000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 214540000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 864110000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 69227250.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 1017390000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 623710000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 11980030000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 247900000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 107530000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 20370000.00
SUDARSCHEM.NS income_statement (quarterly, 2024-09-30) — Other Operating Expenses: 1692840000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 10308040000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1564830000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Payables: 6159890000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 69227250.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 12118480000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 11802140000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 26123700000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 12504790000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 5594070000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 12118480000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 14005220000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 11480540000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 1860410000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 152690000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 2498350000.00
SUDARSCHEM.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 1613000000.00
SUDARSCHEM.NS income_statement (quarterly, 2024-12-31) — Other Special Charges: 308000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — +Operating Expense: 13397000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 5791000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — +Total Revenue: 33456000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 13494000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 13984500000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 13984500000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 12249520000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 12249520000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -7612810000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -7612810000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 9935130000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 9935130000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -379180000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -379180000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Amortization: 96290000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 82950000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 17680000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 17680000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 70759494.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 80000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Basic EPS: 7.90
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Basic EPS: -0.50
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 472000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 9849940000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 9849940000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -946000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 2928570000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2928570000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 157150000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 157150000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 11043250000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 11043250000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 14412020000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 14412020000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -92000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 1615770000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 1615770000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 9427480000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 9427480000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -1864000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -2386000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 1747000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Change In Payable: 2177000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -1237000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -1502000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 10845000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Common Stock: 157150000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 157150000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -92000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 34400500000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 34400500000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 10200000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1437470000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1437470000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 17737000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 6924000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Current Assets: 61671070000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 61671070000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 450610000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 450610000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Current Debt: 4527750000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 4527750000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 4978360000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 4978360000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 29145540000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 29145540000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 937210000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 937210000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Depreciation: 1662000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 1662000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 1662000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 571000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 1662000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 571000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 70759494.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 80000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Diluted EPS: 7.90
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.50
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 559000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -40000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 71610000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 71610000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 0.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — EBIT: 1476000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — EBIT: 316000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — EBITDA: 3138000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — EBITDA: 887000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: -274000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — End Cash Position: 11043000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Financial Assets: 1080000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets: 1080000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 91320000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 91320000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 25961000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 14630880000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 14630880000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -233000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -176000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -6000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 979240000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Goodwill: 68440000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 68440000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 1379780000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1379780000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 12628700000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 12628700000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 37249080000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 37249080000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Gross Profit: 15719000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 6570000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 107410000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 107410000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Interest Expense: 483000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 210000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 483000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 210000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Interest Income: 41670000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 41670000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -445000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 42000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Inventory: 24651810000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 24651810000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 55247140000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 55247140000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -15829000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 109000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 109000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Investments In Other Ventures Under Equity Method: 2102160000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Investments In Other Ventures Under Equity Method: 2102160000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Investmentsin Subsidiariesat Cost: 0.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Subsidiariesat Cost: 0.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 10200000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 15888000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 4650450000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 4650450000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 2477960000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2477960000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 16318890000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 16318890000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 18796850000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 18796850000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 15888000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -1429000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 2102160000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 2102160000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 4923830000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 4923830000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 21311220000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 21311220000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 5982490000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 5982490000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Minority Interests: -44000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Minority Interests: -44000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: -8976000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 10200000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Net Debt: 9803390000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 9803390000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -161000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Net Income: 559000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income: -40000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 559000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -40000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 603000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 4000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 559000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -40000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 559000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -40000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 993000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 603000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 4000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Net Interest Income: -483000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -210000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -2329000000.00